As Chief Technology Officer at Monte Rosa Therapeutics, Sharon brings expertise in lead discovery, structural biology and innovative technology platforms. Sharon joined from Kymera Therapeutics where she served as Executive Director, Head of Platform Biology and was responsible for overseeing their targeted protein degradation platform. She previously served on the senior leadership team at Warp Drive Bio, where she established a novel molecular glue technology platform. Sharon began her career at Pfizer as a structural biologist and holds a Ph.D. in structural biology and biochemistry from the University of Manchester Institute of Technology (UMIST) in the U.K.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5